Desjardins Global Asset Management Inc. Royalty Pharma PLC Call Options Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.34 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$779 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$575 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$479 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...